What is Exacta^™?

Exacta^™ is a comprehensive genomic test designed to identify key genetic alterations and pathways driving cancer, enabling us to understand which treatments might work best against it.

It is a multi-analyte and multi-coordinate investigation that integrates genomic alterations in > 400 genes and perturbation in expressions of 20,802 genes to unravel actionable mutations and pathways propelling cancer. Exacta^™ can identify the most efficacious drugs for every individual cancer and thus enable highly sophisticated treatment strategies beyond the conventional perspective, even for difficult refractory cancers.

How does it work?

Exacta^™ works by analysing the genomic profile of an individual, detecting alterations in genes and shifts in the expression of the genes. This advanced analysis uncovers actionable mutations and cancer-driving pathways, as well as drug toxicity profiles and chemosensitivity analysis, offering key insights to personalise the treatment strategy for that individual.

Why Exacta^™?

It is the most comprehensive multi-analyte test available in the market. It is clinically proven and identifies the most effective drugs for each cancer, enabling advanced treatment strategies even for difficult and unresponsive cases.

When should you consider Exacta^™?

• When your initial treatment has failed.
• If the cancer has recurred.
• If you are detected with cancer that is aggressive or has spread at diagnosis.
• If you are newly diagnosed with hard-to-treat cancers.
• If you are left with limited or no treatment options.
• If you have high risk of therapy failure.